Home > Healthcare > Healthcare IT > Payer/Provider Solutions > Predictive Disease Analytics Market

Predictive Disease Analytics Market Trends

Report ID: GMI10929
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Predictive Disease Analytics Market Trends

Several emerging trends are shaping the predictive disease analytics industry. One significant trend is the increasing adoption of cloud-based solutions. Cloud deployment offers scalability, flexibility, and cost-effectiveness, allowing healthcare organizations to handle large volumes of data and access analytics tools remotely. This shift to the cloud is enhancing data integration and real-time analysis capabilities.

As healthcare evolves towards more individualized care, predictive analytics tools are increasingly used to tailor treatment plans based on patients unique genetic profiles, lifestyle factors, and health histories. This trend enhances the precision of predictions and improves treatment outcomes by ensuring that interventions are specifically suited to each patient’s needs.
Another significant trend is the rise of real-time healthcare analytics and decision support systems. Advances in technology are enabling the development of solutions that provide instantaneous insights and recommendations based on current patient data. This shift towards real-time analytics facilitates quicker, more informed decision-making and enables healthcare professionals to respond promptly to emerging health issues, thereby improving overall patient management and outcomes.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The predictive disease analytics industry was valued at USD 2.5 billion in 2023 and is expected to exhibit 21.7% CAGR from 2024 to 2032 attributed to increasing focus on streamlining of healthcare processes, and extensive advancements in AI and machine learning technologies.

The healthcare payers end-use segment in the market is anticipated to reach USD 9.6 billion by 2032 due to the increasing emphasis on cost control and risk management in the payer sector.

North America predictive disease analytics industry size is anticipated to grow at 20.9% CAGR between 2024 and 2032 driven by the increasing emphasis on value-based healthcare and cost containment.

Anaconda Inc., Allscripts Healthcare Solutions Inc., Apixio Inc., Epic System Corporation, Health Catalyst, IBM, McKesson Corporation, and MedeAnalytics, Inc.